Project description:Snake venom is a rich source of peptides and proteins with a wide range of actions. Many of the components of the venom are currently being tested for their usefulness in the treatment of many diseases ranging from neurological and cardiovascular to cancer. It is also important to constantly search for new proteins and peptides with properties not yet described. The venom of Vipera berus berus has hemolytic, proteolytic and cytotoxic properties, but its exact composition and the factors responsible for these properties are not known. Therefore, an attempt was made to identify proteins and peptides derived from this species venom by using high resolution two-dimensional electrophoresis and MALDI ToF/ToF mass spectrometry. A total of 11 protein classes have been identified mainly proteases but also L-amino acid oxidases, C-type lectin like proteins, cysteine-rich venom proteins and phospholipases A2 and 5 peptides of molecular weight less than 1500 Da. Most of the identified proteins are responsible for the highly hemotoxic properties of the venom. Presence of venom phospholipases A2 and L- amino acid oxidases cause moderate neuro-, myo- and cytotoxicity. All successfully identified peptides belong to the bradikinin-potentiating peptides family.
Project description:This DATASET collection includes the mass spectrometry files for proteomics venom investigation of seven taxa of the genera Vipera, Montivipera, Macrovipera and Daboia across Turkiye/Turkey.
Species list:
Vipera berus barani
Vipera darevskii
Montivipera bulgardaghica bulgardaghica
Montivipera bulgardaghica albizona
Montivipera xanthina
Macrovipera lebetinus obtusa
Daboia palaestinae
Folders - TOP-DOWN PROTEOMICS: The venom pools were investigated by the non-reduced and TCEP reduced top-down (labled as TD) approach and in short: untreated (non-reduced) or TCEP reduced samples submitted to HPLC-MS/MS. Files are included as RAW and MZML format.
Used instrument: Q Exactive HF mass spectrometer (Thermo, Bremen, Germany) with a Vanquish ultra-high performance liquid chromatography (UHPLC) system (Agilent Technologies, Waldbronn, Germany) using a reversed-phase Supelco Discovery BIO wide C18 (2.0 x 150 mm; 3 um particle size; 300 A pore size).
Modifications: none (either red. or non-red. disulfide bridges)